Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.

Archives of pathology & laboratory medicine - 1 Feb 2024

Cornejo Kristine M, Hutchinson Lloyd, O'Donnell Patrick, Meng Xiuling, Tomaszewicz Keith, Shalin Sara C, Cassarino David S, Chan May P, Quinn Timothy R, Googe Paul B, Nazarian Rosalynn M

Abstract excerpt

CONTEXT.—: Syringocystadenocarcinoma papilliferum (SCACP) is a rare adnexal carcinoma and the malignant counterpart of syringocystadenoma papilliferum (SCAP), which is commonly located on the head and neck and may arise in association with a nevus sebaceus. RAS mutations have been identified in both SCAP and nevus sebaceus. OBJECTIVE.—: To evaluate the clinicopathologic and molecular features of SCACPs, which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nevus
Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Share to Skin Neoplasms

Source

Identifiers

PMID: 37074845
DOI: 10.5858/arpa.2022-0474-OA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.PMID 37074845Read ↗

Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.Semantic proximity Read ↗

Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.Semantic proximity Read ↗

Squamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma.Semantic proximity Read ↗

Sialadenoma Papilliferum.Semantic proximity Read ↗

Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum.Semantic proximity Read ↗

Whole-Exome Sequencing of a Case of Squamoid Eccrine Ductal Carcinoma Reveal Similarities With Cutaneous Squamous Cell CarcinomaSemantic proximity Read ↗

Whole-exome sequencing identifies distinct genomic aberrations in eccrine porocarcinomas and poromasSemantic proximity Read ↗

Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinomaSemantic proximity Read ↗

Assessment of TP53 and CDKN2A status as predictive markers of malignant transformation of sinonasal inverted papilloma.Semantic proximity Read ↗

Molecular characterization of squamous cell carcinoma of the anal canalSemantic proximity Read ↗

Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation-specific BRAFV600E immunohistochemistry.Semantic proximity Read ↗

High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.